ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$40.92
+0.25 (+0.61%)
Performance
1D
+0.61%
1W
+13.54%
1M
+18.30%
3M
+13.16%
6M
+38.71%
1Y
+93.29%
YTD
+86.59%
Open$40.60
Previous Close$40.67
Day High$40.95
Day Low$39.88
52W High$42.50
52W Low$19.62
Volume—
Avg Volume7.30M
Market Cap28.08B
P/E Ratio—
EPS$-0.39
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$36.81
Above
SMA 200
$31.94
Above
RSI (14)
69.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+96.6% upside
Current
$40.92
$40.92
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.60M | 16.77M | 2.76B |
| Net Income | -312,043,533 | -547,765,125 | -140,854,131 |
| Profit Margin | -3,629.2% | -3,447.7% | -5.1% |
| EBITDA | -521,228,272 | -965,802,337 | -182,068,335 |
| Free Cash Flow | — | — | -125,369,781 |
| Rev Growth | -48.7% | -48.7% | -1.7% |
| Debt/Equity | — | — | 0.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.16 | +0.29% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.66 | -0.34% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.91 | +0.35% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $550.07 | -0.15% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $911.56 | -0.91% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $151.28 | -3.40% | 7.7 | 20.98B |